Bayn Europe secures external financing of up to SEK 20 million to support the roll-out of EUREBA® and issues free warrants to its shareholders

Bayn Europe has signed an agreement relating to an investment of up to SEK 20 million. The capital will be used for the production and the roll-out of EUREBA®, a natural solution for sugar and calorie reduction, with a consistent quality and taste profile. The transaction is carried out through a private placement of convertible notes (the “Notes”) with warrants attached (the “Warrants”) in several tranches spread over 24 months (each, a “Tranche”). “This investment will enable us to roll-out EUREBA® and produce in enough volumes in order to meet the demand. We are pleased to be able to